Skip to main content
Oxford University Hospitals NHS Foundation Trust
Clinical Haematology

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

MDT by specialty

Lymphoma MDT

The Lymphoma MDT meeting is held weekly.

  • Wednesdays 1.00pm - 3.00pm

Dr Graham Collins is the single named lead clinician for the MDT and Dr Chris Hatton is the Vice Chair.

The Lymphoma MDT comprises consultants from a range of specialties including:

  • chemotherapy
  • radiotherapy
  • radiology
  • pathology (including molecular diagnostics).

These consultants, with the support of Advanced Nurse Practitioners and the wider team, deliver a service that includes the diagnosis and management of all new patients and agreed follow-up of patients with lymphoma within the Thames Valley.

Treatments are based on evidence-based guidelines and protocols available on the Haematology NSSG website.

Myeloid MDT

The Myeloid MDT meeting is held weekly.

  • Thursdays
    • regional meeting one week 11.00am - 12.30pm
    • local meeting the following week 12.30pm - 1.00pm

Prof Paresh Vyas is the single named lead clinician for the MDT and Dr Adam Mead and Dr Andy Peniket are the Vice Chairs.

The Myeloid MDT comprises consultants from a range of specialties including:

  • chemotherapy
  • cytogenetics
  • pathology (including molecular diagnostics).

These consultants, with the support of Advanced Nurse Practitioners and the wider team, deliver a service
that includes the diagnosis and management of all new patients and agreed follow-up of patients with a myeloid disorder within the Thames Valley.

Treatments are based on evidence-based guidelines and protocols available on the Haematology NSSG website.

Myeloma and Plasma-cell Dyscrasia MDT

The Myeloma and Plasma-cell Dyscrasia MDT meeting is held fortnightly.

  • Thursdays 11.00am - 12.30pm

Dr Karthik Ramasamy is the Chair and Dr Robin Aitchison, Consultant Haematologist at Bucks Hospitals NHS Trust, is the Vice Chair.

The Myeloma and Plasma-cell Dyscrasia MDT comprises consultants from a range of specialties including:

  • chemotherapy
  • radiotherapy
  • radiology
  • pathology (including molecular diagnostics).

These consultants, with the support of Advanced Nurse Practitioners and the wider team, deliver a service that includes the diagnosis and management of all new patients and agreed follow-up of patients with myeloma and plasma-cell dyscrasia within the Thames Valley.

Treatments are based on evidence-based guidelines and protocols available on the Haematology NSSG website.

Blood and Marrow Transplant (BMT) MDT

The BMT MDT meeting is held twice monthly.

  • Every 2nd and 4th Monday 12.00 noon - 1.30pm
  • Haematology Seminar Room, Level 1, Cancer and Haematology Centre

Dr Andy Peniket is the BMT Programme Director and the named clinician for the MDT.

The BMT MDT comprises:

  • consultants from the Lymphoma, Myeloma and Myeloid teams
  • BMT Nurse Practitioner and Coordinators
  • BMT Fellow
  • Transplant Immunologist(s)
  • BMT MDT Coordinator.

In order to ensure that key members can participate, teleconference is available.

Treatments are based on evidence-based guidelines and protocols available on the Haematology NSSG website.